Total assets increased 58.6%
Total assets changed +58.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$7.4B→$11.7B4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →PLTR financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Trade receivables increased 98.7%
Trade receivables changed +98.7% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$747.5M→$1.5B4 prior comparisons
Working capital increased 64.9%
Working capital changed +64.9% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$5.8B→$9.6B4 prior comparisons
Current assets increased 61.1%
Current assets changed +61.1% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
$6.9B→$11.1B4 prior comparisons
Working capital / assets moved 314 bp higher
Working capital / assets changed +314 basis points from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
78.75%→81.89%4 prior comparisons
Operating income increased 238.6%
Operating income changed +238.6% from the comparable as-filed period.
$269.3M→$912.0M2 prior comparisons
Free-cash-flow proxy increased 126.0%
Free-cash-flow proxy changed +126.0% from the comparable as-filed period.
$531.6M→$1.2B3 prior comparisons
Operating cash flow increased 125.5%
Operating cash flow changed +125.5% from the comparable as-filed period.
$539.3M→$1.2B3 prior comparisons
Current liabilities increased 40.9%
Current liabilities changed +40.9% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
$1.1B→$1.5B4 prior comparisons
Operating margin moved 2029 bp higher
Operating margin changed +2029 basis points from the comparable as-filed period.
26.83%→47.12%2 prior comparisons
Net income increased 225.0%
Net income changed +225.0% from the comparable as-filed period.
$326.7M→$1.1B2 prior comparisons
Revenue increased 92.8%
Revenue changed +92.8% from the comparable as-filed period.
$1.0B→$1.9B2 prior comparisons
Gross margin moved 388 bp higher
Gross margin changed +388 basis points from the comparable as-filed period.
80.78%→84.66%2 prior comparisons
Gross profit increased 102.1%
Gross profit changed +102.1% from the comparable as-filed period.
$810.8M→$1.6B2 prior comparisons
Cash & equivalents increased 118.4%
Cash & equivalents changed +118.4% from the comparable as-filed period.
$929.5M→$2.0B2 prior comparisons
Research & development increased 42.6%
Research & development changed +42.6% from the comparable as-filed period.
$135.0M→$192.5M2 prior comparisons
Cost of revenue increased 53.9%
Cost of revenue changed +53.9% from the comparable as-filed period.
$192.9M→$296.9M2 prior comparisons
Stock-based compensation increased 65.8%
Stock-based compensation changed +65.8% from the comparable as-filed period.
$160.0M→$265.2M2 prior comparisons
Capital expenditure increased 90.6%
Capital expenditure changed +90.6% from the comparable as-filed period.
$7.6M→$14.6M3 prior comparisons
Free-cash-flow margin moved 912 bp higher
Free-cash-flow margin changed +912 basis points from the comparable as-filed period.
52.97%→62.08%2 prior comparisons
Operating cash-flow margin moved 911 bp higher
Operating cash-flow margin changed +911 basis points from the comparable as-filed period.
53.73%→62.84%2 prior comparisons
R&D / revenue moved 351 bp lower
R&D / revenue changed -351 basis points from the comparable as-filed period.
13.45%→9.95%2 prior comparisons
Operating cash flow / net income decreased 30.6%
Operating cash flow / net income changed -30.6% from the comparable as-filed period.
1.65→1.152 prior comparisons
SBC / revenue moved 224 bp lower
SBC / revenue changed -224 basis points from the comparable as-filed period.
15.94%→13.70%2 prior comparisons
Current ratio increased 14.3%
Current ratio changed +14.3% from the comparable as-filed period. The change ranks at the 75th percentile of 4 prior comparable changes.
6.32→7.234 prior comparisons
Receivables / revenue moved 227 bp higher
Receivables / revenue changed +227 basis points from the comparable as-filed period.
74.47%→76.74%2 prior comparisons
Capex / revenue moved 1 bp lower
Capex / revenue changed -1 basis points from the comparable as-filed period.
0.76%→0.75%2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.